SMYD3 and ovarian cancer: In ovarian cancer, shRNA-mediated knockdown of SMYD3 decreases spheroid invasion and adhesion by suppressing integrin subunit beta 6 (ITGB6) and integrin subunit alpha M (ITGAM).